Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5615281 | Journal of Clinical Lipidology | 2016 | 11 Pages |
Abstract
Patients with severe HTG are at a higher risk of developing AP. A number of comorbidities, risk factors, and baseline TG levels are associated with an increased incidence of AP. Patients with severe HTG are underdiagnosed, undertreated and are nonadherent to their index lipid therapy. There is a need to better define optimal approaches to treating severe HTG so as to reduce the incidence of AP. Economic studies are also needed to evaluate the burden of AP on various health care systems.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nazia PharmD, MS, Puza P. MBBS, MPH, PhD, Ronald D. MD, Kathy J. MS, Peter P. MD, PhD,